Navigation Links
MU establishes National Botanical Research Center
Date:10/8/2010

COLUMBIA, Mo. Americans spend $25 billion a year on dietary supplement products such as herbs and other botanicals. While the Nutrition Business Journal forecasts that sales of botanical dietary supplements will increase by about 19 percent over the next five years, scientists still don't know the precise properties that make certain plants helpful or harmful to humans. Now, with a new $7.5 million grant from the National Institutes of Health, University of Missouri researchers have created a National Botanical Research Center to answer these questions.

"Despite their widespread use, the safety and efficacy of these products have not been adequately studied," said Dennis Lubahn, principal investigator of the project, director of the center at MU and a professor of biochemistry and child health in the School of Medicine and the College of Agriculture, Food and Natural Resources.

MU's Center for Botanical Interaction Studies will focus on five different plants and their abilities to aid in the prevention of strokes and prostate cancer, as well as improve resistance to infectious diseases. Garlic, elderberries and soy are among the botanicals that will be studied.

Grace Sun, professor of biochemistry, pathology and anatomical sciences and a member of the MU Interdisciplinary Neuroscience Program, will lead a team of neuroscientists to investigate how botanicals may suppress stroke damage in the brain. The brain consumes 20 percent of circulating oxygen in our body and uses oxygen for many reactions, Sun said.

"Plants contain an array of chemicals that help our bodies cope with oxygen and oxidative stress," said Kevin Fritsche, a project leader for the grant and professor of animal sciences, nutritional sciences and molecular microbiology and immunology in the MU School of Medicine and College of Agriculture, Food and Natural Resources. "Oxygen is essential for life, but when it's handled inappropriately by the body's cells, oxygen can have damaging toxic effects to body function and lead to disease."

A team of more than 20 human, animal and plant scientists at MU will study how the botanicals use antioxidant properties to protect people from disease.

Because the potency of wild plants can vary, researchers at MU and elsewhere are cultivating their own. MU is cultivating 600 types of soybean seeds to study different concentrations of the same compounds in the plants and how they might work to prevent prostate cancer. MU also is growing 60 types of elderberries to study the plant's possible role in boosting the immune system against infection and fighting cancer and inflammation in the body. Lubahn said there may be variations in individual plants that will make a difference in how well they fight disease.


'/>"/>

Contact: Christian Basi
BasiC@missouri.edu
573-882-4430
University of Missouri-Columbia
Source:Eurekalert

Related biology news :

1. Genome comparison of ants establishes new model species for molecular research
2. DFG establishes 12 new research training groups
3. Covance Establishes New Discovery & Translational Services Group
4. Covance Establishes New Discovery & Translational Services Group
5. Innovalight Establishes New Record With Silicon Ink Solar Cells
6. DFG establishes 10 new research units
7. TGen Drug Development establishes European footprint
8. March of Dimes establishes 2 new perinatal bioethics awards
9. MU research team establishes family tree for cattle, other ruminants
10. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
11. The last supper of the hominids establishes the times they lived at the sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 ... growing at a compound annual growth rate (CAGR) of 24.0% ... global markets for synthetic biology. - Analyses of global market ... of compound annual growth rates (CAGRs) through 2021. - Coverage ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm announces its ... to fill a critical niche in technical and policy ... Mark Crego and Janice Kephart together ... that span federal governments, the 9/11 Commission, private industry, ... has a common theme born from a shared passion ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017 Research and Markets has ... Markets" report to their offering. ... The ... parts, delivery plasmids, chassis organisms, synthetic cells, production systems), ... editing, bioinformatics and specialty media) and enabled technologies (biofuels, ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017 UCHealth ( Aurora, ... LungDirect for pulmonary nodule patient management. In addition to ... a spot on the lung, UCHealth looks to improve ... data entry. Stephanie Brown, RN , ... nodule patients with an Excel spreadsheet, which was extremely ...
(Date:2/16/2017)... -- Champions Oncology, Inc. (NASDAQ: CSBR ), a ... technology solutions and products to personalize the development and ... new cohorts of PDX models to their existing TumorBank. ... product line in hepatocellular cancer, breast cancer, castrate resistant ... cell lung cancer (including EGFR mutation; ALK/ROS1 positive) PDX ...
Breaking Biology Technology: